Published: 22 January 2016
Author(s): Maud A.W. Hermans, Mark J.A. Rietveld, Jan A.M. van Laar, Virgil A.S.H. Dalm, Maurice Verburg, Suzanne G.M.A. Pasmans, Roy Gerth van Wijk, P. Martin van Hagen, Paul L.A. van Daele
Section: Original Article
Systemic mastocytosis (SM) is a rare heterogeneous disease which is characterized by the aberrant proliferation of mast cells. It can be divided into various subtypes with different phenotypes and prognoses. Here, we report on the clinical characteristics of 136 SM patients.